| Stage | LIFE | % of rev | SEZL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $190M | 100.00% | $150M | 100.00% | LIFE ×1.27 |
| Gross profit | $186M | 97.88% | $135M | 90.16% | LIFE +7.7pp |
| Operating income | $18M | 9.56% | $55M | 36.72% | SEZL +27.2pp |
| Pre-tax income | $19M | 10.19% | $52M | 34.55% | SEZL +24.4pp |
| Net income | $20M | 10.30% | $41M | 27.23% | SEZL +16.9pp |
| Stage | LIFE | SEZL | Gap · A − B |
|---|---|---|---|
| Revenue | $190M100.00% | $150M100.00% | LIFE ×1.27 |
| Gross profit | 97.88%$186M | 90.16%$135M | LIFE +7.7pp |
| Operating income | 9.56%$18M | 36.72%$55M | SEZL +27.2pp |
| Pre-tax income | 10.19%$19M | 34.55%$52M | SEZL +24.4pp |
| Net income |
| 10.30%$20M |
| 27.23%$41M |
| SEZL +16.9pp |
No shared counterparties.